On March 27, 2020, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”)—a sweeping economic relief package that will deliver an unprecedented $2 trillion to businesses, governments, and individuals impacted by the coronavirus. With the historic size and scope of the CARES Act, however, comes the potential for widespread fraud and abuse, and the inevitable investigation and prosecution of that conduct.